(From the June 2019 Issue of MedStat)
Anne M. Connolly, MD, is chief of the Division of Neurology at Nationwide Children’s Hospital, professor of Pediatrics at The Ohio State University College of Medicine, and a member of the Center for Gene Therapy in the Abigail Wexner Research Institute. An internationally recognized expert in pediatric neuromuscular disease and neuroimmunology, Dr. Connolly’s early research examined the relationship between auto-antibodies and childhood neurological disorders, including chronic immune-mediated demyelinating polyneuropathy (CIDP), opsoclonus myoclonus syndrome (OMS), Landau-Kleffner syndrome, epilepsy and autism. She has also helped develop outcome measures for infants and boys with Duchenne muscular dystrophy (DMD), and has led or been a collaborator in numerous pivotal clinical trials in children with neuromuscular disorders.
Dr. Connolly has published 90 peer-reviewed articles, 18 invited reviews and chapters and given more than 40 invited lectures. She is associate editor for the Journal of Child Neurology. She has served as a national thought leader for multiple foundation and government agency efforts to improve outcomes in children with neuromuscular disorders. She is an American Academy of Neurology Fellow, and member of the Child Neurology Society and the World Muscle Society.